Rationale of Combined Chemotherapy of Brain Tumours

In this review dealing with the rationale for combination chemotherapy of brain tumours, two main issues will be considered: (a) what are the characteristics of brain tumours most likely to determine the choice of chemotherapeutic drugs, and (b) is there any clinical evidence supporting the view that combination chemotherapy is superior to single-drug therapy in human brain neoplasms.